CONGRESSIONAL TESTIMONY

   On July 26, 2006, the United States House of Representatives Committee on Government Reform Subcommittee on Criminal Justice, Drug Policy, and Human Resources convened hearings to address the growing problem of prescription drug abuse.

   Officials from key government agencies testified on the extent and causes of the problem and on current government efforts to reduce prescription drug abuse. Parents of young people who died from misuse of addictive prescription drugs also described their tragic experiences. Mathea Falco, President of Drug Strategies and a leader of the Keep Internet Neighborhoods Safe initiative, testified about new strategies the KINS collaboration has developed to curtail illegal internet drug sales. Additional witnesses discussed other aspects of the problem as well as possible responses, including a public advertising campaign by the Partnership for a Drug-Free America.

   Transcripts of the statements of those who testified are available below.

•Opening Statement of Mark Souder, Chairman
•Statement of Bertha Madras, Deputy Director for Demand Reduction at the White House  Office of National Drug Control Policy
•Statement of Sandra Kweder, Deputy Director in the Office of New Drugs, Center for Drug  Evaluation and Review, at the Food and Drug Administration
•Statement of Joe Rannazzisi, Deputy Assistant Administrator for the Office of Diversion  Control in the Drug Enforcement Administration
•Statement of Dr. Nora D. Volkow, Director of the National Institute on Drug Abuse
•Statement of Misty Fetco
•Statement of Linda Surks
•Statement of Barbara van Rooyan

•Testimony of Mathea Falco President, Drug Strategies
•Statement of Stephen E. Johnson Executive Director, Commercial Planning Pain  Therapeutics, Inc
•Statement of Laxmaiah Manchikanti, CEO of the American Society of Interventional Pain  Physicians
•Testimony of Steve Pasierb, President and CEO of the Partnership for a Drug-Free America